University of Minnesota. Driven to Discover.
Also, a new study found that 47% of Kenyan camels tested had evidence of MERS-CoV antibodies.
A UC–Santa Cruz team has developed a chip-based method to directly detect Ebola.
The CDDEP report and maps provide an unprecedented look at the problem and include a range of data, some public for the first time.
The first two phase 1 trials of VSV-EBOV vaccine show good immune responses.
Steeply dropping cases, though, may cause the NIAID to vary from the original trial design.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.